FDA Action Alert: MacroGenics and Amgen
The Pharma Data
DECEMBER 13, 2020
MacroGenics , based in Rockville, Maryland, has a target action date of December 18 for its Biologics License Application (BLA) for margetuximab in combination with chemotherapy for patients with metastatic HER2+ breast cancer. Zai Lab is leading clinical development in its territory. “We Read on for this week’s.
Let's personalize your content